128 related articles for article (PubMed ID: 1325792)
1. Comparative effects of protein phosphatase inhibitors (okadaic acid and calyculin A) on human leukemia HL60, HL60/ADR and K562 cells.
Sakurada K; Zheng B; Kuo JF
Biochem Biophys Res Commun; 1992 Aug; 187(1):488-92. PubMed ID: 1325792
[TBL] [Abstract][Full Text] [Related]
2. Mitotic arrest and enhanced nuclear protein phosphorylation in human leukemia K562 cells by okadaic acid, a potent protein phosphatase inhibitor and tumor promoter.
Zheng B; Woo CF; Kuo JF
J Biol Chem; 1991 Jun; 266(16):10031-4. PubMed ID: 1645333
[TBL] [Abstract][Full Text] [Related]
3. Multidrug-resistant human KB carcinoma cells are highly resistant to the protein phosphatase inhibitors okadaic acid and calyculin A. Analysis of potential mechanisms involved in toxin resistance.
Chambers TC; Raynor RL; Kuo JF
Int J Cancer; 1993 Jan; 53(2):323-7. PubMed ID: 8093882
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of protein phosphatase type 1 and 2A attenuate phosphatidylinositol metabolism and Ca(2+)-transients in human platelets. Role of a cdc2-related protein kinase.
Lerea KM
Biochemistry; 1992 Jul; 31(28):6553-61. PubMed ID: 1321663
[TBL] [Abstract][Full Text] [Related]
5. T cell apoptosis induced by interleukin-2 deprivation or transforming growth factor-beta 2: modulation by the phosphatase inhibitors okadaic acid and calyculin A.
Weller M; Malipiero U; Groscurth P; Fontana A
Exp Cell Res; 1995 Dec; 221(2):395-403. PubMed ID: 7493639
[TBL] [Abstract][Full Text] [Related]
6. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity.
Ishihara H; Martin BL; Brautigan DL; Karaki H; Ozaki H; Kato Y; Fusetani N; Watabe S; Hashimoto K; Uemura D
Biochem Biophys Res Commun; 1989 Mar; 159(3):871-7. PubMed ID: 2539153
[TBL] [Abstract][Full Text] [Related]
7. Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD-1 mouse skin.
Suganuma M; Fujiki H; Furuya-Suguri H; Yoshizawa S; Yasumoto S; Kato Y; Fusetani N; Sugimura T
Cancer Res; 1990 Jun; 50(12):3521-5. PubMed ID: 2160320
[TBL] [Abstract][Full Text] [Related]
8. Protein phosphatase inhibitors okadaic acid and calyculin A alter cell shape and F-actin distribution and inhibit stimulus-dependent increases in cytoskeletal actin of human neutrophils.
Kreienbühl P; Keller H; Niggli V
Blood; 1992 Dec; 80(11):2911-9. PubMed ID: 1333304
[TBL] [Abstract][Full Text] [Related]
9. Human leukemia K562 cell mutant (K562/OA200) selected for resistance to okadaic acid (protein phosphatase inhibitor) lacks protein kinase C-epsilon, exhibits multidrug resistance phenotype, and expresses drug pump P-glycoprotein.
Zheng B; Chambers TC; Raynor RL; Markham PN; Gebel HM; Vogler WR; Kuo JF
J Biol Chem; 1994 Apr; 269(16):12332-8. PubMed ID: 7512966
[TBL] [Abstract][Full Text] [Related]
10. Protein phosphatase inhibitors and bone resorption: inhibition by okadaic acid and biphasic actions of calyculin-A.
Goad DL; Meurer EA; Voelkel EF; Petrou CP; Tashjian AH
Endocrinology; 1992 Jun; 130(6):3402-10. PubMed ID: 1375901
[TBL] [Abstract][Full Text] [Related]
11. Protein phosphatase inhibitors induce the sustained expression of the Egr-1 gene and the hyperphosphorylation of its gene product.
Cao X; Mahendran R; Guy GR; Tan YH
J Biol Chem; 1992 Jun; 267(18):12991-7. PubMed ID: 1320009
[TBL] [Abstract][Full Text] [Related]
12. Protein phosphatase inhibitors, okadaic acid and calyculin A, induce alkaline phosphatase activity in osteoblastic cells derived from newborn mouse calvaria.
Murata T; Shirakawa S; Takehara T; Kobayashi S; Haneji T
Biochem Mol Biol Int; 1995 Jun; 36(2):365-72. PubMed ID: 7663440
[TBL] [Abstract][Full Text] [Related]
13. The effects of okadaic acid and calyculin A on thrombin induced platelet reaction.
Murata K; Sakon M; Kambayashi J; Yukawa M; Ariyoshi H; Shiba E; Kawasaki T; Kang J; Mori T
Biochem Int; 1992 Feb; 26(2):327-34. PubMed ID: 1313673
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of serine/threonine phosphoprotein phosphatases alter circadian properties in Gonyaulax polyedra.
Comolli J; Taylor W; Rehman J; Hastings JW
Plant Physiol; 1996 May; 111(1):285-91. PubMed ID: 8685268
[TBL] [Abstract][Full Text] [Related]
15. Okadaic acid indicates a major function for protein phosphatases in stimulus-response coupling of RINm5F rat insulinoma cells.
Mayer P; Jochum C; Schatz H; Pfeiffer A
Exp Clin Endocrinol; 1994; 102(4):313-9. PubMed ID: 7813603
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of action of okadaic acid class tumor promoters on mouse skin.
Fujiki H; Suganuma M; Yoshizawa S; Nishiwaki S; Winyar B; Sugimura T
Environ Health Perspect; 1991 Jun; 93():211-4. PubMed ID: 1663450
[TBL] [Abstract][Full Text] [Related]
17. Differential induction of apoptosis in human breast tumor cells by okadaic acid and related inhibitors of protein phosphatases 1 and 2A.
Kiguchi K; Glesne D; Chubb CH; Fujiki H; Huberman E
Cell Growth Differ; 1994 Sep; 5(9):995-1004. PubMed ID: 7819137
[TBL] [Abstract][Full Text] [Related]
18. Induction of differentiation and c-jun expression in human leukemic cells by okadaic acid, an inhibitor of protein phosphatases.
Adunyah SE; Unlap TM; Franklin CC; Kraft AS
J Cell Physiol; 1992 May; 151(2):415-26. PubMed ID: 1315324
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of retinoic acid-induced granulocytic differentiation in HL-60 leukemia cells by serine/threonine protein phosphatase inhibitors.
Morita K; Nishikawa M; Kobayashi K; Deguchi K; Ito M; Nakano T; Shima H; Nagao M; Kuno T; Tanaka C
FEBS Lett; 1992 Dec; 314(3):340-4. PubMed ID: 1334850
[TBL] [Abstract][Full Text] [Related]
20. The protein phosphatase inhibitors, okadaic acid and calyculin A, induce apoptosis in human submandibular gland ductal cell line HSG cells.
Morimoto Y; Morimoto H; Kobayashi S; Ohba T; Haneji T
Oral Dis; 1999 Apr; 5(2):104-10. PubMed ID: 10522205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
